Cefuracetime

This classification denotes a cephalosporin antibiotic with the molecular formula C17H17N3O8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F69EA18270, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((2-furanyl(methylimino)acetyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but more generally known as cefuracetime, which bears US NIH Compound Identifier 9571078. European Medicines Agency schedules Cefuracetime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07432MIG. The term CEFURACETIME is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 35, No. 5 1981, List 21). CEFURACETIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefuracetime under HS 29419000 and SITC 54139. As of Q4 2014, CEFURACETIME remains US FDA's Preferred Term for this commodity. Cefuracetime bears US NLM identifiers UMLS ID C2699151 and NCI Concept Code C76177. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N\OC)C2OCCC2)C(=C(C1)COC(=O)C)C(=O)O.